Search

everythinglearnresearchcommunity

for

Search:↓

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

New biofabrication technologies could lead to treatments for hair loss.

Innovative methods are reducing animal testing and improving biomedical research.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Cell-based screening methods are useful and cost-effective for drug discovery but have pros and cons.

3D bioprinting could solve organ shortages and improve drug testing.

Standardizing and engineering organoids can improve their use in medicine and drug testing.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

New technologies replicate human skin for testing without animals.

Microfluidic technology improves cell spheroid creation for better drug testing and tissue engineering.

3D-bioprinting models of pancreatic cancer could help personalize treatments but need more testing.

Organoids can revolutionize medicine by modeling diseases and aiding in personalized treatments.

Organoids created from stem cells are used to model diseases, test drugs, and develop personalized and regenerative medicine.

Single-cell encapsulation shows promise for medical use but faces production challenges.

Bioprinting shows promise in medicine but needs collaboration to overcome challenges.

iPSCs are promising for studying and treating COVID-19.

Advancements in cultured models improve understanding and treatment of gallbladder cancer.

Smart microneedles using advanced tech could improve psoriasis treatment.

AI-enhanced smart patches can personalize drug delivery for better treatment outcomes.

3D bioprinting is useful for making tissues, testing drugs, and delivering drugs, but needs better materials, resolution, and scalability.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

AI improves biomaterial design by making it faster, cheaper, and more effective for personalized medicine.

New methods may speed up drug development for male subfertility.

Hair follicle organoids can help study hair biology and disorders but need improvements for wider use.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

3D-printed microneedles improve drug delivery and diagnostics but face scalability and regulatory challenges.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Using existing drugs for new treatments is cost-effective and safer.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.